Brain Researcher Ian Maze Has Upended Scientific Dogma and Forged New Areas for Therapeutic Discovery
For decades, scientific dogma held that the chemicals dopamine and serotonin served as messengers within the central nervous system, allowing brain cells, or neurons, to communicate with each other. Known as neurotransmitters, dopamine and serotonin also contribute to...
Higher Risk of Autism Found in Babies Born Prematurely According to a Definitive New Mount Sinai Study
Premature birth is linked to an increased risk of autism spectrum disorder (ASD) in both males and females, with those born earliest carrying the highest risk, according to a large and definitive new study in Pediatrics from the Icahn School of Medicine at Mount...
Pandemic’s Toll on Mount Sinai Front-Line Staff Is Surveyed, and Addressed
Front-line staff who were already feeling burnout showed the most signs of mental distress during the height of the COVID-19 pandemic, while those who fared best had an active social network and felt supported by their supervisors. These were among the many lessons...
Mount Sinai Creates COVID-19 Vaccine for Low- and Middle-lncome Countries
The development of a safe, effective, and inexpensive COVID-19 vaccine that can easily be produced and distributed in low- and middle-income countries is underway at the Icahn School of Medicine at Mount Sinai, where early phase 1 clinical testing in Vietnam and...
Improving Diversity in Autism Genomic Research
Genomic research is now an integral part of the study and treatment of autism spectrum disorder (ASD) and related neurodevelopmental disabilities, so it is crucial to include more ethnically and racially diverse populations, said Pilar Trelles, MD, a psychiatrist and...
A Major Breakthrough and Potential New Treatment for Children With an Inflammatory Blood Disease
A 17-year quest to understand Langerhans-cell histiocytosis (LCH)—an inflammatory blood disease that mostly affects children and can result in dementia and death—has led researchers at the Icahn School of Medicine at Mount Sinai and their colleagues in Texas to a...
Mount Sinai Establishes the First Link Between Ultrafine Air Pollutants and Asthma in Children
The link between prenatal exposure to ultrafine particles in air pollution and the development of asthma in preschool-age children has been established for the first time in the United States by a team of scientists led by Rosalind J. Wright, MD, MPH, Dean for...
Mount Sinai Awarded $42 Million to Prepare for Future Pandemics and Advance Influenza Research
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded the Icahn School of Medicine at Mount Sinai a seven-year contract valued at more than $42 million to advance basic research into influenza and COVID-19, and prepare for future pandemics....
COVID-19 Research Roundtable
Almost exactly one year ago, New York City faced the outbreak and first peak of the pandemic, and the city accounted for 25 percent of COVID-19 deaths in the United States. Mount Sinai Health System and health care workers responded to an unprecedented surge of...
